Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Details)

v3.22.1
NET LOSS PER SHARE (Details)
3 Months Ended
Mar. 31, 2022
shares
Warrant  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Potentially dilutive shares 1,582,227
Stock Options  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Potentially dilutive shares 2,437,500